Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

ECOG Performance Status 0

Known as: ECOG 0 
Fully active, able to carry on all pre-disease performance without restriction.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
3533Background: FOLFOXIRI/Bevacizumab (Bev) is superior to FOLFIRI/Bev in the TRIBE trial (F Loupakis, NEJM 2014). The CHARTA… Expand
Is this relevant?
2016
2016
BackgroundFew new compounds are available for relapsed osteosarcoma. We retrospectively evaluated the activity of gemcitabine (G… Expand
  • table 1
  • table 2
  • figure 1
  • table 3
  • table 4
Is this relevant?
Highly Cited
2015
Highly Cited
2015
OBJECTIVES In patients with advanced incurable lung cancer deciding as to the most appropriate treatment (e.g., chemotherapy or… Expand
Is this relevant?
2012
2012
PURPOSE We retrospectively analyzed the results of patients with locally advanced unresectable pancreatic cancer (LAPC) treated… Expand
  • table 1
  • table 2
  • table 3
  • figure 1
  • table 4
Is this relevant?
2011
2011
UNLABELLED New therapeutic approaches are being developed based on the findings that several genetic abnormalities underlying… Expand
  • table 1
  • table 2
  • figure 1
  • table 3
  • figure 3
Is this relevant?
2010
2010
4556 Background: Eribulin mesylate (E7389), a synthetic analog of halichondrin B, is a novel tubulin-binding agent that inhibits… Expand
Is this relevant?
2010
2010
AIM We evaluated the effect of comorbidities on clinical outcomes in patients with advanced non-small cell lung cancer (NSCLC… Expand
Is this relevant?
Review
2003
Review
2003
Stage IV non-small cell lung cancer (NSCLC) denotes the presence of metastatic disease and is largely incurable using present-day… Expand
  • table 1
  • table 2
  • table 3
  • figure 1
  • table 4
Is this relevant?
Highly Cited
2002
Highly Cited
2002
In advanced cancer patients, the oxidative stress could take place either at the onset of disease or as a function of disease… Expand
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Malignant pleural mesothelioma is often unresectable at diagnosis, is refractory to cytotoxic agents and is frequently… Expand
Is this relevant?